Knockdown of IL-32 in MM cells by shRNA reduced the enhancing effect toward BMSCs (246.7±10.9 pg/mL vs 360.8±28.4 pg/mL, p<0.05). The gene discussed is IL32; the disease is Miyoshi myopathy.